AR047684A1 - Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroides - Google Patents
Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroidesInfo
- Publication number
- AR047684A1 AR047684A1 ARP050100568A ARP050100568A AR047684A1 AR 047684 A1 AR047684 A1 AR 047684A1 AR P050100568 A ARP050100568 A AR P050100568A AR P050100568 A ARP050100568 A AR P050100568A AR 047684 A1 AR047684 A1 AR 047684A1
- Authority
- AR
- Argentina
- Prior art keywords
- decongestive
- inflammatories
- compositions
- decongestant
- histamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formas de dosificacion mejoradas de fármacos para el tratamiento de la rinitis asociada con alergias y resfríos. Las formas de dosificacion incluyen una cantidad efectiva de un fármaco anti-inflamatorio no esteroide (NSAID), como por ejemplo Ibuprofeno, y un descongestivo, como por ejemplo pseudoefedrina, o un anti-histamínico, caracterizado en que la cantidad efectiva del descongestivo o del anti-histamínico, como por ejemplo clorfeniramina, es menor que 75 % de la cantidad presente en una dosis aprobada del descongestivo o anti-histamínico en relacion con una cantidad de NSAID que corresponde a alrededor del 100 % de la cantidad presente en una dosis de potencia normal del NSAID. Método de preparacion de la composicion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54545804P | 2004-02-17 | 2004-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR047684A1 true AR047684A1 (es) | 2006-02-01 |
Family
ID=34886158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100568A AR047684A1 (es) | 2004-02-17 | 2005-02-17 | Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroides |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050192355A1 (es) |
| EP (1) | EP1720537A4 (es) |
| AP (1) | AP2006003747A0 (es) |
| AR (1) | AR047684A1 (es) |
| AU (1) | AU2005214018A1 (es) |
| CA (1) | CA2555383A1 (es) |
| TW (1) | TW200529805A (es) |
| WO (1) | WO2005079272A2 (es) |
| ZA (1) | ZA200607678B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2527568T3 (es) | 2009-10-26 | 2015-01-26 | Sephoris Pharmaceuticals, Llc | Tratamiento de quemaduras solares usando analgésicos y antihistamínicos |
| CA3199168A1 (en) * | 2020-12-04 | 2022-06-09 | Laboratorios Silanes S.A. De C.V. | Pharmaceutical composition of an analgaesic and an antihistamine forthe treatment of respiratory diseases |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU738274B2 (en) * | 1984-04-09 | 2001-09-13 | Procter & Gamble Company, The | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
| US5288479A (en) * | 1989-01-17 | 1994-02-22 | Sterling Drug, Inc. | Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof |
| US5025109A (en) * | 1989-12-29 | 1991-06-18 | Mobil Oil Corporation | Process for upgrading methane to higher hydrocarbons |
| AU8505991A (en) * | 1990-09-11 | 1992-03-30 | Richardson-Vicks Inc. | Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders |
| EP0577757A1 (en) * | 1991-04-01 | 1994-01-12 | Merck & Co. Inc. | Ibuprofen-decongestant combinations |
| EP0674527A1 (en) * | 1992-12-21 | 1995-10-04 | The Procter & Gamble Company | Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders |
| US5466865A (en) * | 1993-07-02 | 1995-11-14 | Ibah, Inc. | Neomorphic ibuprofen and methods of using same |
| CA2170488A1 (en) * | 1993-09-07 | 1995-03-16 | Sekhar Mitra | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| EP1014983A1 (en) * | 1997-09-19 | 2000-07-05 | The Procter & Gamble Company | Naproxen/cetirizine compositions and methods for treating respiratory disorders |
| WO2003089007A1 (en) * | 2002-04-22 | 2003-10-30 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| WO2005063219A2 (en) * | 2003-12-23 | 2005-07-14 | Ranbaxy Laboratories Limited | Ibuprofen-containing soft gelatin capsules |
-
2005
- 2005-02-10 US US11/055,338 patent/US20050192355A1/en not_active Abandoned
- 2005-02-11 WO PCT/US2005/004238 patent/WO2005079272A2/en active Application Filing
- 2005-02-11 AU AU2005214018A patent/AU2005214018A1/en not_active Abandoned
- 2005-02-11 CA CA002555383A patent/CA2555383A1/en not_active Abandoned
- 2005-02-11 AP AP2006003747A patent/AP2006003747A0/xx unknown
- 2005-02-11 EP EP05722916A patent/EP1720537A4/en not_active Withdrawn
- 2005-02-16 TW TW094104475A patent/TW200529805A/zh unknown
- 2005-02-17 AR ARP050100568A patent/AR047684A1/es unknown
-
2006
- 2006-09-13 ZA ZA200607678A patent/ZA200607678B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005214018A1 (en) | 2005-09-01 |
| TW200529805A (en) | 2005-09-16 |
| WO2005079272A3 (en) | 2006-02-23 |
| WO2005079272A2 (en) | 2005-09-01 |
| ZA200607678B (en) | 2010-03-31 |
| EP1720537A2 (en) | 2006-11-15 |
| AP2006003747A0 (en) | 2006-10-31 |
| US20050192355A1 (en) | 2005-09-01 |
| WO2005079272B1 (en) | 2006-08-17 |
| EP1720537A4 (en) | 2007-10-03 |
| CA2555383A1 (en) | 2005-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
| AR045972A1 (es) | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas | |
| AR048705A1 (es) | Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
| AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
| AR060836A1 (es) | Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido | |
| MX2009013574A (es) | Formas de dosificacion solidas o semisolidas de liberacion modificada. | |
| AR054064A1 (es) | Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas | |
| TW200609004A (en) | Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihistamines | |
| CL2011002858A1 (es) | Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor. | |
| AR054833A1 (es) | Formas de dosificacion de liberacion retardada oral altamemte biodisponibles de succinato de o-desmetilvenlafaxina | |
| ECSP10010224A (es) | Formulaciones líquidas de hormona luteinizante (lh). | |
| AR039164A1 (es) | Sales de venlafaxina de baja solubilidad en agua | |
| AR042543A1 (es) | Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroides | |
| CL2007002875A1 (es) | Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales. | |
| AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
| CL2011000798A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| DE602006016127D1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
| DK2043637T3 (da) | Fremgangsmåder og medikamenter til administrering af ibuprofen | |
| CL2007002574A1 (es) | Composicion farmaceutica oral que comprende levodopa en una dosis unitaria de alrededor de 100 hasta alrededor de 500 mg y un excipiente adecuado; y su uso para tratar parkinson. | |
| AR051968A1 (es) | Metodos y composiciones que utilizan inhibidores de jnk para el tratamiento y manejo de la lesion del sistema nervioso central | |
| UY32109A (es) | Métodos para utilizar composiciones de liberación sostenida de aminopiridina | |
| AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
| AR030957A1 (es) | Composiciones de analgesico y glucosamina | |
| AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
| ES2563068T3 (es) | Tratamiento de esclerosis múltiple (MS) con Campath-1H |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |